Inner Mitochondrial Membrane Cardiolipin-Stabilizing Tetrapeptide · CAS 736992-21-5

FDA Label Reference (NDA 215244) · Research Vial · MW 639.79 g/mol (C32H49N9O5 free base) ·

SS-31 (Elamipretide / MTP-131 Cardiolipin-Targeting Tetrapeptide)

Vial sizes:
lyophilized vial
mg
0.9% benzyl alcohol
mL
1 mg = 1,000 mcg
mg
4. Insulin Syringe Barrel U-100 (100u/mL) or U-40
Draw to 5 mg/mL (50 mcg/u)
40 Units (0.4 mL)
2 mg (2000 mcg) · 0.4 mL · 5 mg/mL · ≈ 5 doses/vial
0255075100 40 u
Delivers 2 mg (2000 mcg) at 50 mcg per U-100 unit.
FRIDGE VIAL STICKER DATE MIXED: ________ · IN-VITRO LAB
SS-31 (Elamipretide) 10mg + 2mL BAC = 5 mg/mL (40u = 2mg)
SS-31 (Elamipretide) · 10mg Documented SKU$6.00–$8.55/labeled mg
1 matching 10mg batch COA linked
Batch-Attributed Assay: True Peptides (Lot #261002, 10mg): RP-HPLC Purity (99.9%, spec >=95%) + LC-MS Identity Confirmation (SS-31; quantitative mg/vial fill weight not reported on certificate) (In-vitro analytical batch data only; does not establish clinical safety.)
Embed
U-100: 100 units = 1.00 mL

Clinical Overview & Worked Dilution Specifications

SS-31 (Elamipretide) (10mg Vial) — Summary & Reconstitution Math

SS-31 (Elamipretide / MTP-131, D-Arg-Dmt-Lys-Phe-NH2, C32H49N9O5, CAS 736992-21-5) is a mitochondria-penetrating aromatic-cationic tetrapeptide that binds selectively to cardiolipin on the inner mitochondrial membrane to stabilize cristae curvature and electron transport chain supercomplexes. Elamipretide received FDA accelerated approval in 2025 as Forzinity (NDA 215244) for Barth syndrome. Reconstituting a 10 mg research vial with 2.0 mL bacteriostatic water yields 5.0 mg/mL (50 mcg/unit on a U-100 syringe; a 2.0 mg aliquot equals 40 Units).

Direct Answer (SS-31 (Elamipretide) 10mg Vial): Reconstituting a 10 mg SS-31 (Elamipretide) vial with 2 mL of bacteriostatic water produces a 5 mg/mL solution (50 mcg per U-100 unit). For a 2 mg (2000 mcg) hypothetical aliquot, draw 40 Units (0.4 mL) on a U-100 syringe (5 aliquots/vial; Documented (FDA Label NDA 215244) — multi-day accumulation model omitted).

Standard Dilution
10mg + 2mL = 5 mg/mL
Hypothetical U-100 Aliquot
40 Units (2 mg)
Human SC PK Status
Documented (FDA Label NDA 215244)
Molecular Weight & CAS
639.79 g/mol (C32H49N9O5 free base) · 736992-21-5

Reference Volumetric Dilution Tiers (No Standardized Clinical Regimen)

Reference Volumetric Dilution Table — SS-31 (Elamipretide)

10mg + 2mL (5 mg/mL)
Volumetric Reference Note: Reference dilution arithmetic only (1.0 mg, 2.0 mg, 4.0 mg, and 5.0 mg mass-to-volume conversions for a 10 mg vial reconstituted with 2.0 mL bacteriostatic water = 5.0 mg/mL; at 40 mg daily in clinical trials such as TAZPOWER and MMPOWER-2, high-concentration clinical formulations were used). Unapproved research vials are not bioequivalent to FDA-approved Forzinity (NDA 215244).
Phase Dose Volume U-100 Doses
1 mg (1000 mcg) 0.2 mL 20 u 10
2 mg (2000 mcg) 0.4 mL 40 u 5
4 mg (4000 mcg) 0.8 mL 80 u 2.5
5 mg (5000 mcg) 1 mL 100 u 2

Select any row button to load that target dose into the syringe calculator and half-life simulator.

SS-31 (Elamipretide) Vial Charts:

Syringe Units by Diluent Volume

SS-31 (Elamipretide) 10mg — BAC Water Chart

U-100 (100u = 1.0 mL)
Dose +1 mL BAC10 mg/mL+1.5 mL BAC6.67 mg/mL+2 mL BAC5 mg/mL+3 mL BAC3.33 mg/mL
1 mg 10 u 0.1 mL 15 u 0.15 mL 20 u 0.2 mL 30 u 0.3 mL
2 mg 20 u 0.2 mL 30 u 0.3 mL 40 u 0.4 mL 60 u 0.6 mL
4 mg 40 u 0.4 mL 60 u 0.6 mL 80 u 0.8 mL 120 u 1.2 mL
5 mg 50 u 0.5 mL 75 u 0.75 mL 100 u 1 mL 150 u 1.5 mL

More BAC water lowers concentration and gives a wider, easier-to-read draw on the syringe barrel.

Volumetric Reference Draw Tiers · Non-Clinical

Documented (FDA Label NDA 215244)

Reference Volumetric Draw Ladder & Chemical Identity

Human SC PK Status
Documented (FDA Label NDA 215244)
Multi-Day Accumulation
Omitted (Renal-Dependent PK)
CAS Registry Number
736992-21-5
Free-Base Molecular Wt.
639.79 g/mol (C32H49N9O5 free base)

Pharmacokinetic & Chemical Identity Evidence Boundary

Why Multi-Day Systemic Accumulation Is Omitted (SS-31 (Elamipretide))

1. Pharmacokinetic Evidence Scope
Human subcutaneous pharmacokinetics and renal-impairment exposure relationships for elamipretide (SS-31 / MTP-131) are documented in the 2025 FDA Forzinity prescribing information (NDA 215244, §12.3) and subcutaneous clinical trials (TAZPOWER, Reid Thompson et al., Genet Med 2021, PMID: 33077895; MMPOWER-2, Karaa et al., J Cachexia Sarcopenia Muscle 2020, PMID: 32096613). Multi-day pharmacokinetic superposition graphing is intentionally omitted here because the simplified 1-compartment web model is not validated for elamipretide’s renal-function-dependent disposition (and M1/M2 metabolite clearance) or for unapproved lyophilized research vials.
2. Chemical Identity & Counter-Ion Mass Basis (4 amino acids (H-D-Arg-Dmt-Lys-Phe-NH2 · C32H49N9O5))
Free-base aromatic-cationic tetrapeptide formula C32H49N9O5 (D-Arg-2',6'-dimethyl-L-tyrosine-L-Lys-L-Phe-NH2, MW 639.79 g/mol, CAS 736992-21-5). Clinical formulations have been studied as hydrochloride or acetate salts; in 2025, elamipretide received FDA accelerated approval as Forzinity (NDA 215244) for Barth syndrome. True Peptides (10 mg SKU TP-SS10) publishes Optiq Health Labs Lot #261002 (COA UID: 1704.OPT.261012-R1, tested 2026-10-14) reporting 99.9% RP-HPLC purity and LC-MS identity confirmation without quantitative mg/vial net content; its 50 mg SKU (TP-SS50) has no separate 50 mg batch COA located. Simms Research (10 mg SKU) has no public batch COA located as of 2026-11-04.
3. Reference Dilution vs. Clinical Regimen
Reference dilution arithmetic only (1.0 mg, 2.0 mg, 4.0 mg, and 5.0 mg mass-to-volume conversions for a 10 mg vial reconstituted with 2.0 mL bacteriostatic water = 5.0 mg/mL; at 40 mg daily in clinical trials such as TAZPOWER and MMPOWER-2, high-concentration clinical formulations were used). Unapproved research vials are not bioequivalent to FDA-approved Forzinity (NDA 215244).
PepLab.wiki enforces strict evidence boundaries: first-order superposition curves are rendered only when human pharmacokinetic parameters are published in peer-reviewed or regulatory literature.

Quick Clinical Reference · 10mg Vial

Common Questions — SS-31 (Elamipretide) (10mg)

How much bacteriostatic water do I mix with a 10mg SS-31 (Elamipretide) vial?

Adding 2 mL of bacteriostatic water (0.9% benzyl alcohol) to a 10 mg SS-31 (Elamipretide) lyophilized vial yields a concentration of 5 mg/mL (50 mcg per U-100 unit). For a hypothetical 2 mg (2000 mcg) aliquot, that corresponds to 40 Units (0.4 mL) on a standard U-100 insulin syringe.

How many units on a U-100 syringe is 2 mg of SS-31 (Elamipretide) (10mg vial)?

When a 10 mg SS-31 (Elamipretide) vial is reconstituted with 2 mL of bacteriostatic water (5 mg/mL), a hypothetical 2 mg (2000 mcg) aliquot equals 0.4 mL, or 40 Units on a 100-unit (1.0 mL) U-100 syringe.

How many aliquots are in a 10mg SS-31 (Elamipretide) vial at 2 mg per aliquot?

A 10 mg SS-31 (Elamipretide) vial provides 5 nominal aliquots at 2 mg (2000 mcg) per draw (10 mg ÷ 2 mg = 5). Note that post-reconstitution chemical stability varies by peptide sequence, diluent composition, and storage temperature; always consult compound-specific analytical stability data.

What is the elimination half-life and steady-state timeline of SS-31 (Elamipretide)?

SS-31 (Elamipretide / MTP-131 Cardiolipin-Targeting Tetrapeptide) (CAS 736992-21-5, MW 639.79 g/mol (C32H49N9O5 free base)): Human subcutaneous pharmacokinetics and renal-impairment exposure relationships for elamipretide (SS-31 / MTP-131) are documented in the 2025 FDA Forzinity prescribing information (NDA 215244, §12.3) and subcutaneous clinical trials (TAZPOWER, Reid Thompson et al., Genet Med 2021, PMID: 33077895; MMPOWER-2, Karaa et al., J Cachexia Sarcopenia Muscle 2020, PMID: 32096613). Multi-day pharmacokinetic superposition graphing is intentionally omitted here because the simplified 1-compartment web model is not validated for elamipretide’s renal-function-dependent disposition (and M1/M2 metabolite clearance) or for unapproved lyophilized research vials.

How do I convert SS-31 (Elamipretide) milligrams (mg) or micrograms (mcg) to U-100 syringe units?

Use the three-step dilution formula: (1) Concentration = 10 mg ÷ 2 mL = 5 mg/mL; (2) Volume (mL) = 2 mg ÷ 5 mg/mL = 0.4 mL; (3) U-100 Syringe Units = 0.4 mL × 100 = 40 Units.

Complete Protocol Index · 25 Reference Peptides & Blends

Switch peptide or multi-compound blend

GLP-1 / Metabolic t½ 6d
Retatrutide
Triple Agonist (GLP-1R / GIPR / GCGR)
10mg + 2mL (5 mg/mL) 40u →
GLP-1 / Metabolic t½ 5d
Tirzepatide
Dual Incretin Agonist (GIPR / GLP-1R)
15mg + 1.5mL (10 mg/mL) 25u →
GLP-1 / Metabolic t½ 7d
Semaglutide
Selective GLP-1 Receptor Agonist
5mg + 2mL (2.5 mg/mL) 10u →
GLP-1 / Metabolic t½ 7.5d
Cagrilintide
Dual Amylin & Calcitonin Receptor Agonist (DACRA)
5mg + 2mL (2.5 mg/mL) 10u →
GLP-1 / Metabolic Blend
CagriSema 10mg
1:1 Dual Amylin + GLP-1 Co-Formulation Blend
10mg + 2mL (5 mg/mL) 10u →
GLP-1 / Metabolic t½ 4.6d
Survodutide
Dual Glucagon / GLP-1 Receptor Agonist
10mg + 2mL (5 mg/mL) 12u →
Regenerative & Blend Blend
GLOW 70mg Blend
5:1:1 Triple Regenerative Peptide Blend
70mg + 3mL (23.33 mg/mL) 10u →
Regenerative & Blend Blend
KLOW 80mg Blend
5:1:1:1 Quad Regenerative & Anti-Inflammatory Blend
80mg + 3mL (26.67 mg/mL) 12u →
Regenerative & Blend Blend
Wolverine 20mg
1:1 Dual Tendon & Connective Tissue Blend
20mg + 2mL (10 mg/mL) 5u →
Regenerative & Blend t½ 0.25d
BPC-157
Tendon, Ligament & Mucosal Cytoprotective Peptide
5mg + 2mL (2.5 mg/mL) 10u →
Regenerative & Blend t½ 2.5d
TB-500
Actin-Sequestering & Cellular Migration Peptide
10mg + 2mL (5 mg/mL) 40u →
Regenerative & Blend t½ 0.5d
GHK-Cu
Extracellular Matrix & Gene Expression Remodeler
50mg + 3mL (16.67 mg/mL) 12u →
GH Secretagogue Blend
CJC / Ipamorelin 10mg
1:1 Synergistic GHRH + Ghrelin Mimetic Blend
10mg + 2.5mL (4 mg/mL) 5u →
GH Secretagogue t½ 0.5d
Tesamorelin
Growth Hormone-Releasing Hormone (GHRH 1-44) Analogue
10mg + 2mL (5 mg/mL) 20u →
GH Secretagogue t½ 0.25d
Ipamorelin
Selective GHS-R1a Ghrelin Receptor Agonist
5mg + 2.5mL (2 mg/mL) 12.5u →
Longevity & Neuro t½ 1.5d
MOTS-c
Mitochondrial AMPK & Folate-Methionine Regulator
10mg + 2mL (5 mg/mL) 100u →
Longevity & Neuro t½ 1d
NAD+ 500mg
Cellular Redox Coenzyme & Sirtuin (SIRT1-7) Substrate
500mg + 5mL (100 mg/mL) 50u →
Longevity & Neuro t½ 0.5d
Epithalon
Telomerase Activator & Pineal Circadian Tetrapeptide
10mg + 2mL (5 mg/mL) 20u →
Regenerative & Blend t½ N/A (Preclinical)
KPV
PepT1-Transported Anti-Inflammatory Tripeptide (α-MSH 11-13)
10mg + 2mL (5 mg/mL) 10u →
Longevity & Neuro t½ N/A (Preclinical)
DSIP
Neuroendocrine & Slow-Wave Sleep Nonapeptide
10mg + 2mL (5 mg/mL) 5u →
Longevity & Neuro t½ N/A (Preclinical)
Melanotan II
Non-Selective Cyclic Melanocortin (MC1R/MC3R/MC4R/MC5R) Agonist
10mg + 2mL (5 mg/mL) 5u →
Longevity & Neuro Documented (FDA Label t½ 2.7h)
PT-141
Cyclic Heptapeptide Melanocortin Agonist (MC1R / MC4R)
10mg + 2mL (5 mg/mL) 35u →
Longevity & Neuro Documented (FDA Label NDA 215244)
SS-31 (Elamipretide)
Inner Mitochondrial Membrane Cardiolipin-Stabilizing Tetrapeptide
10mg + 2mL (5 mg/mL) 40u →
GH Secretagogue Documented (IV Infusion t½ ~4m)
Kisspeptin-10
KISS1R (GPR54) Hypothalamic GnRH / LH Pulse Secretagogue
10mg + 2mL (5 mg/mL) 4u →
Longevity & Neuro t½ N/A (Preclinical)
Selank
Tuftsin-Derived Anxiolytic & Enkephalinase-Modulating Heptapeptide
10mg + 2mL (5 mg/mL) 5u →

Affiliate Partner Directory & Independent Lab Verifiers

Documented & Illustrative $/mg Lookup — SS-31 (Elamipretide) 10mg

FTC Affiliate, Pricing & Laboratory Research Disclosure: Supplier links (Visit Supplier →) are commercial referral links from which PepLab.wiki may earn a commission. Entries marked Documented Catalog Price link directly to the verified supplier product URL and listed vial price on the stated check date; entries marked Illustrative Est. (~$…/mg est.) are model estimates where no public product page is linked. All listed materials are strictly for in-vitro laboratory research and not for human consumption. Request the lot-specific RP-HPLC & Mass Spec certificate from the supplier and verify the batch number on the Kovera / Simms Lab COA Index ↗ or True Peptides COA Index ↗ before use.
True PeptidesDocumented (10mg Exact SKU)
Supplier-published 10mg batch COA linked (Lot #261002) — verify current lot on delivery
Pricing: Documented 10mg vial ($60.00 catalog price; partner ref peplab) · Pack: 1 vial (10mg SKU TP-SS10 In Stock; 50mg SKU TP-SS50 Backorder) · Variant link: Select 10mg variant on supplier product page (10mg, 50mg carried) (10mg SKU status: In Stock) · Price checked: 2026-11-04 · Report test date: 2026-10-14 · Report checked: 2026-11-04 · COA PDF (Optiq Health Labs, LLC · COA UID: 1704.OPT.261012-R1 (Sample ID: 1704.OPT.261012)): RP-HPLC Purity (99.9%, spec >=95%) + LC-MS Identity Confirmation (SS-31; quantitative mg/vial fill weight not reported on certificate)
$6.00/labeled mg
$60.00 (10mg catalog SKU)
Bergdorf BioscienceDocumented (10mg Exact SKU)
No public batch COA located as of 2026-11-04 — request lot COA from supplier
Pricing: Documented 10mg vial ($94.99 standard list / $9.50/mg; $85.49 / $8.55/mg w/ -10% referral code BIO-QTVGWU) · Pack: 1 vial (10mg lyophilized powder) · Variant link: Single 10mg SKU on supplier product page (10mg SKU status: In Stock) · Price checked: 2026-11-06 · Report test date: Unlinked · Report checked: Unverified
$8.55/labeled mg (w/ code · $9.50/mg list)
$85.49 w/ referral code ($94.99 standard list · 10mg SKU)
Simms ResearchIllustrative Est. (10mg ref)
No batch-specific report linked here — request lot COA from supplier
Pricing: Illustrative estimate (verify live price on supplier site) · Variant link: Catalog homepage link — verify SKU and vial size availability on supplier site · Price checked: Unverified · Report test date: Unlinked · Report checked: Unverified
~$7.47/mg est.
~$74.70 est. vial
Affiliate Partner COA & Verification Status Vial Price $ / Labeled mg Partner Code Source, Verifier & Supplier
True Peptides
US Fulfillment (UK/EU/CA/AU Shipping Unconfirmed) · Active Affiliate · Documented Catalog Price
Supplier-published 10mg batch COA linked (Lot #261002) — verify current lot on delivery
Pricing: Documented 10mg vial ($60.00 catalog price; partner ref peplab) · Pack: 1 vial (10mg SKU TP-SS10 In Stock; 50mg SKU TP-SS50 Backorder) · Variant link: Select 10mg variant on supplier product page (10mg, 50mg carried) (10mg SKU status: In Stock) · Price checked: 2026-11-04 · Report date: 2026-10-14 · Checked: 2026-11-04 · COA PDF (Optiq Health Labs, LLC · COA UID: 1704.OPT.261012-R1 (Sample ID: 1704.OPT.261012)): RP-HPLC Purity (99.9%, spec >=95%) + LC-MS Identity Confirmation (SS-31; quantitative mg/vial fill weight not reported on certificate)
$60.00(10mg catalog SKU)$6.00/labeled mgNo code needed (Partner Link)
Bergdorf Bioscience
EU & US Tracked Dispatch (Ships from Germany · $9.99 US / Free ≥$250) · Active Affiliate · Documented Catalog Price
No public batch COA located as of 2026-11-04 — request lot COA from supplier
Pricing: Documented 10mg vial ($94.99 standard list / $9.50/mg; $85.49 / $8.55/mg w/ -10% referral code BIO-QTVGWU) · Pack: 1 vial (10mg lyophilized powder) · Variant link: Single 10mg SKU on supplier product page (10mg SKU status: In Stock) · Price checked: 2026-11-06 · Report date: Unlinked · Checked: Unverified
$85.49(w/ referral code; $94.99 standard list · 10mg SKU)$8.55/labeled mg (w/ code · $9.50/mg list)
Simms Research
US Domestic (Tampa, FL · UK/EU/CA/AU Unconfirmed) · Active Affiliate · Illustrative Price Estimate
No batch-specific report linked here — request lot COA from supplier
Pricing: Illustrative estimate (verify live price on supplier site) · Variant link: Catalog homepage link — verify SKU and vial size availability on supplier site · Price checked: Unverified · Report date: Unlinked · Checked: Unverified
~$74.70(est.)~$7.47/mg est.